Recruiting now—Ages 0 Years to 89 Years

Histiocytic Disorder Follow-up Study

Sponsor: University of Alabama at Birmingham · NCT05915208 on ClinicalTrials.gov ↗

Conditions studied

HistiocytosisLangerhans Cell HistiocytosisErdheim-Chester DiseaseRosai Dorfman DiseaseXanthogranulomaMalignant Histiocytoses

Where it's running1 site

University of Alabama at Birmingham
Birmingham, Alabama 35233
Recruiting now
- Gaurav Goyal, MD(contact)1-866-438-1640 [email protected]

See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* diagnosis of histiocytic disorder at any age

  1. Langerhans cell histiocytosis,
  2. Erdheim-Chester disease,
  3. Rosai-Dorfman disease,
  4. Xanthogranuloma,
  5. Mixed histiocytosis
  6. Malignant histiocytosis (Histiocytic sarcoma, langerhans cell sarcoma, interdigitating cell sarcoma)
  7. Hemophagocytic lymphohistiocytosis

Exclusion Criteria:

* None

Updated 2026-06-12 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.